ライフサイエンスコーパス: acute pyelonephritis

1 ed urinary tract infection (cUTI), including acute pyelonephritis.

2 le with prostatic hyperplasia presented with acute pyelonephritis.

3 f the kidneys, leading to the development of acute pyelonephritis.

4 isolates obtained in 1994-96 from women with acute pyelonephritis.

5 d from the blood and urine of a patient with acute pyelonephritis.

6 ansplantation, but there were no episodes of acute pyelonephritis.

7 l reflux, and the diagnosis and follow-up of acute pyelonephritis.

8 onse against uropathogenic, E. coli-induced, acute pyelonephritis.

9 ted from the blood and urine of a woman with acute pyelonephritis.

10 ted from the blood and urine of a woman with acute pyelonephritis.

11 imaging test of choice for the diagnosis of acute pyelonephritis.

12 peutic tool to prevent renal scarring during acute pyelonephritis.

13 with complicated urinary tract infection or acute pyelonephritis.

14 rom clinical isolates (67 from patients with acute pyelonephritis, 38 from patients with cystitis, 49

15 ns associated with the clinical syndromes of acute pyelonephritis (79%) and cystitis (82%) than in th

16 the clinical syndromes of cystitis (82%) and acute pyelonephritis (79%) than in fecal strains (19%; P

17 t of complicated urinary tract infection and acute pyelonephritis and had a similar safety profile.

18 mbalance in promoting host susceptibility to acute pyelonephritis and the development of permanent re

19 for the empiric treatment of cUTI (including acute pyelonephritis), and may offer an alternative to c

20 the patients had complicated UTI, 42.2% had acute pyelonephritis, and 13.1% had bacteremia.

21 ified in ABU and fecal strains compared with acute pyelonephritis, and a Pol II antagonist suppressed

22 ow-up of focal functional disorders, such as acute pyelonephritis, and for accurate quantitation of s

23 ained at presentation identify children with acute pyelonephritis, and scans obtained six months late

24 mplicated urinary tract infection (cUTI) and acute pyelonephritis (AP) in the United States.

25 we evaluated the value of DNI in predicting acute pyelonephritis (APN) or vesicoureteral reflux (VUR

26 Acute pyelonephritis (APN) versus acute rejection (AR) i

27 is being used for the investigation of focal acute pyelonephritis (APN), especially in children with

28 ith a clinical and laboratorial diagnosis of acute pyelonephritis (APN), who underwent both DW MR and

29 In acute pyelonephritis, bacterial resistance to co-trimoxa

30 More serious infections, characterized as acute pyelonephritis, can also develop.

31 em for the treatment of complicated UTIs and acute pyelonephritis caused by Enterobacteriaceae, inclu

32 Among patients with complicated UTI or acute pyelonephritis caused by gram-negative pathogens,

33 h a clinical diagnosis of complicated UTI or acute pyelonephritis caused by gram-negative urinary pat

34 Acute pyelonephritis causes significant morbidity, tends

35 in the more-virulent strains (those causing acute pyelonephritis) demonstrated a resistance, in aera

36 To date, the cellular mechanisms underlying acute pyelonephritis-driven renal scarring remain unknow

37 P. mirabilis bacteriuria may lead to acute pyelonephritis, fever, and bacteremia.

38 so be seen in some other conditions, such as acute pyelonephritis; for this reason, one must be caref

39 patients with noncalculous disease, two with acute pyelonephritis had perinephric edema at CT.

40 ureteric reflux (VUR) in the pathogenesis of acute pyelonephritis has been downgraded with the recogn

41 ilis to colonize the urinary tract and cause acute pyelonephritis in an experimental model of ascendi

42 atory mediator cAMP significantly attenuated acute pyelonephritis in mice induced by UPEC.

43 is beneficial for controlling UPEC-mediated acute pyelonephritis in mice.

44 er, the authors describe the epidemiology of acute pyelonephritis in South Korea by using nationwide

45 ytotoxic for cultured renal cells and causes acute pyelonephritis in transurethrally infected CBA mic

46 d urinary tract infections (UTIs), including acute pyelonephritis, in a 1:1 ratio to receive intraven

47 ted urinary tract infection (UTI), including acute pyelonephritis, in a 2:1 ratio to receive intraven

48 Cystitis and acute pyelonephritis, infection of the bladder and kidne

49 Acute pyelonephritis is a potentially life-threatening i

50 he sensitivity of SPECT for the detection of acute pyelonephritis is slightly better than pinhole DMS

51 sults demonstrate that in the early stage of acute pyelonephritis kidney tubules participate actively

52 Is into three categories; febrile upper UTI (acute pyelonephritis), lower UTI (cystitis), and asympto

53 e 1990s from women in the United States with acute pyelonephritis (n = 170), cystitis (n = 83), or no

54 Although most cases of acute pyelonephritis occur in otherwise healthy women, d

55 ns) with lower respiratory tract infections, acute pyelonephritis, or primary bloodstream infection w

56 y diversions exposed grafts to more frequent acute pyelonephritis (P = 0.02).

57 oli strains from different clinical sources (acute pyelonephritis patients, cystitis patients, and fe

58 or vaso-occlusive crisis, asthma crisis, and acute pyelonephritis per 1000 children with SCD over the

59 sensitive and reliable for the detection of acute pyelonephritis; power Doppler US is significantly

60 Experimental neutropenia during acute pyelonephritis resulted in a compensatory increase

61 iated with severe human infections including acute pyelonephritis, sepsis, and neonatal meningitis.

62 ins associated with the clinical syndrome of acute pyelonephritis than by faecal strains (P = 0.029).

63 In children, the acute pyelonephritis that can result from urinary tract

64 el of uropathogenic Escherichia coli-induced acute pyelonephritis to determine the contribution of ne

65 ECT and pinhole imaging for the detection of acute pyelonephritis using histology as the standard of

66 Acute pyelonephritis was diagnosed in 61 percent of the

67 3, isolated from the blood of a patient with acute pyelonephritis, was most cytotoxic and most virule

68 uspected or microbiologically confirmed cUTI/acute pyelonephritis were randomized 1:1 to ceftazidime-

69 coureteral reflux (VUR) is a risk factor for acute pyelonephritis, which can result in renal scarring

70 ients infected with Escherichia coli develop acute pyelonephritis, while other patients with bacteriu

71 ts with clinical and laboratory diagnosis of acute pyelonephritis, who were referred for radiological

72 the treatment of complicated UTIs, including acute pyelonephritis, with a noninferiority margin of 15

73 e treatment of complicated UTI that included acute pyelonephritis, with a safety profile similar to t